THE STUDY COMPARES THE EFFECTS OF ISOBARIC LEVOBUPIVACAINE 0.25 percent AGAINST ISOBARIC ROPIVACAINE 0.25 percent IN ULTRASOUND GUIDED BILATERAL SUPERFICIAL CERVICAL PLEXUS BLOCK FOR POSTOPERATIVE ANALGESIA IN PATIENTS UNDERGOING THYROID OPERATIONS UNDER GENERAL ANAESTHESIA

A Comparative study to evaluate the effect of ultrasound guided bilateral superficial cervical plexus block for postoperative analgesia using isobaric bupivacaine 0.25 percent versus isobaric ropivacaine 0.25 percent in patients undergoing thyroid surgeries under general anaesthesia - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081905

Enrollment

Registered

2025-03-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Inj levobupivacaine 0.25%: inj levobupivacaine 0.25% 5ml with 5ml NS given for superficial cervical plexus block given bilaterally Control Intervention1: Inj ropivacaine 0.25%: Inj ropi

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA Class I and II patients posted for elective thyroidectomy under general anesthesia. 2. Age group between 18-60 years of both the gender who are willing to participate and has given informed consent.

Exclusion criteria

Exclusion criteria: Know to have allergy to any of study drugs Any local infection Any history of pulmonary, cardiac, renal, endocrine disorders Previous cervical surgery Pre-existing peripheral nerve neuropathies Patients with history of coagulation disorders or any history of anticoagulant intake

Design outcomes

Primary

Measure	Time frame
To study the duration of postoperative analgesia after superficial cervical plexus blockTimepoint: Till the first complain of postoperative pain	—

Secondary

Measure	Time frame
Evaluate requirement of analgesics in post operative period. To assess and compare the perioperative hemodynamic characteristics between the two drugs To assess complications and or side effect among drugsTimepoint: Post op day 0 and 1	—

Countries

India

Contacts

Public ContactDr Soundarya T N

Chamarajanagara Medical college

darshanms_jss@yahoo.com9741376797

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026